Emergence of New Mpox Strain in England

Health authorities in the UK have confirmed the discovery of a new strain of mpox, formerly known as monkeypox, in an individual who has recently returned from Asia. This emerging variant comprises characteristics from two prominent strains of the mpox virus.

Officials are currently evaluating the implications of this newly identified strain. The UK Health Security Agency (UKHSA) emphasized that viral evolution is a common occurrence.

Vaccination continues to be the most effective way to guard against severe illness associated with mpox, even though many cases present mild symptoms. The new variant has not yet been assigned a specific name.

Strain Characteristics and Recommendations

This strain includes components from clade Ib and clade IIb of the mpox virus. Recently, UK health officials urged gay, bisexual, and other men who have sex with men to ensure they are vaccinated against mpox.

This advisory follows observations of the clade Ib strain beginning to show signs of local transmission in several European nations. The clade IIb strain was responsible for a widespread global mpox outbreak in 2022, impacting numerous countries.

In the UK, vaccination is accessible to individuals deemed at the highest risk for contracting mpox. Officials assert that the vaccine offers a 75-80% effectiveness rate against the virus.

Understanding the New Variant

While there has been no research specifically assessing the vaccine’s effectiveness against this latest strain, it is believed that a considerable level of protection remains. Dr. Katy Sinka, who leads the sexually transmitted infections division at UKHSA, noted that genomic analysis has facilitated the detection of this strain.

“It’s normal for viruses to change, and further investigation will enhance our understanding of how mpox is evolving,” she stated. “Vaccination is a proven method to protect against severe disease, so I urge everyone eligible to get vaccinated.”

Prof. Trudie Lang, director of the Global Health Network at the University of Oxford, highlighted the effective systems in place in the UK for identifying cases and managing infections. However, she acknowledged that such measures are more challenging in less developed regions where vaccine access is limited.

Global Context and Health Implications

If additional cases of this strain emerge in the UK or elsewhere, understanding its transmission and severity will be crucial in determining its potential threat compared to previous variants. As of 2025, there have been nearly 48,000 confirmed global mpox cases, with 2,500 reported in the last month, predominantly in central Africa.

Dr. Boghuma Titanji, an assistant professor of medicine at Emory University, expressed concerns that the new strain aligns with expert predictions regarding the ongoing global spread of mpox.

“The more the mpox virus circulates, the greater the chances it has to recombine and adapt, solidifying its place as a persistent human pathogen,” she remarked.

Mpox can lead to uncomfortable symptoms, including lesions or rashes that may persist for two to four weeks, along with fever, headaches, back pain, and fatigue. The virus spreads through close contact, respiratory droplets, and by touching contaminated fabrics like clothing or bedding.

Health officials advise anyone suspecting they have mpox to reach out to NHS 111 for guidance on the next steps to take.